Professor Klaus Dugi is Executive Vice-President and Chief Medical Officer at Ferring Phramaceuticals, a position he has held since October 2017. Professor Dugi is responsible for Global Medical Affairs, Quality Assurance, Pharmacovigilance, RWE/HEOR and eHealth. Prior to joining Ferring, Professor Dugi held various leadership roles at Boehringer Ingelheim, including Vice President Global Medical Affairs and Chief Medical Officer, and most recently, Managing Director UK & Ireland. As a Professor of Medicine, with a specialty in internal medicine, he continues to teach medicine at Heidelberg University in Germany. He also spent four years carrying out research at the US National Institutes of Health (NIH) and has published more than 70 manuscripts in peer-reviewed journals including The Lancet and Diabetes.